跳至主要内容
临床试验/EUCTR2013-002062-39-IT
EUCTR2013-002062-39-IT进行中(未招募)不适用

Safety and efficacy of propranolol eye drops in neonates with retinopathy of prematurity: a pilot study (DROP-ROP). - DROP-ROP trial

Azienda Ospedaliero-Universitaria Meyer0 个研究点开始时间: 2013年9月23日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Preterm newborns (gestational age lower than 32 weeks) who develop stage 2 ROP (zone II without plus).
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 55
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1. Newborns with heart failure, bradycardia, atrioventricular blocks, congenital cardiovascular anomalies, hypotension, renal failure, failure to thrive, cerebral haemorrhage, other diseases that contraindicate the use of beta-blockers.
  • 2. Newborns with ROP at a more advanced stage than stage 2 (zone II without plus).

研究者

相似试验

Safety and efficacy of propranolol eye drops in... | 临床试验